Contents

postauthoriconWritten by EMCDDA | Print
User Rating: / 0
PoorBest 
Reports - EMCDDA Report on the risk assessment of GHB

Drug Abuse

Foreword

Abbreviations

Introduction

Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs

Europol–EMCDDA progress report on GHB in accordance with Article 3 of the joint action of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs

Use of GHB as a medicinal product (EMEA)

Review of the pharmacotoxicological data on gamma-hydroxybutyric acid (GHB)

Sociological and criminological (Europol) evidence on the risks of GHB

Public health risks of GHB — epidemiological evidence

References

Participants in the risk-assessment process

Next >
 

Show Other Articles Of This Author